Journal of Guangxi Normal University(Natural Science Edition) ›› 2023, Vol. 41 ›› Issue (3): 155-162.doi: 10.16088/j.issn.1001-6600.2022042901

Previous Articles     Next Articles

Origin and Functional Verification of IL-10 in Tumor Tissue of Lung Cancer Mice

HE Liu1,2,3, LIN Chao1,2,3, LI Peihua1,2,3, CHENG Zhixiu1,2,3, ZHU Yu1,2,3, PU Shiming1,2,3, ZHOU Zuping1,2,3*   

  1. 1. School of Life Sciences, Guangxi Normal University, Guilin Guangxi 541006, China;
    2. Guangxi University Key Laboratory of Stem Cell and Biopharmaceutical Technology (Guangxi Normal University), Guilin Guangxi 541004, China;
    3. Research Center for Biomedical Sciences, Guangxi Normal University, Guilin Guangxi 541004, China
  • Received:2022-04-29 Revised:2022-06-06 Online:2023-05-25 Published:2023-06-01

PDF (PC)

53

Abstract: To investigate the expression and source of interleukin-10 (IL-10) in lung cancer tumor tissues, and to investigate the effect of IL-10 on tumors. The levels of IL-10 in the serum of Lewis lung carcinoma mouse model were detected by MSD hypersensitive electrochemiluminescence assay, the main source of IL-10 in tumor tissues was analyzed using flow cytometry, and the effects of IL-10 recombinant protein on proliferation, apoptosis and migration of lung cancer cells were examined by CCK-8 assay, annexin V-propidium iodide (annexin V-PI) apoptosis assay and scratch wound assay. The results showed that the serum levels of IL-10 were significantly increased in Lewis lung carcinoma mice compared with normal mice, and IL-10 in tumor tissues was mainly produced by immune cells, including B cells and myeloid-derived suppressor cells (MDSCs), which were the main source of IL-10, and the recombinant protein of IL-10 could significantly inhibit the proliferation and migration and promote the apoptosis of LLC (mouse Lewis lung carcinoma line). IL-10 level was closely related to lung cancer, B cells and MDSCs were the main source of IL-10 production, and IL-10 may play an antitumor role by activating CD8 T cells or directly acting on tumor cells.

Key words: lung cancer, IL-10, cell origin, function

CLC Number:  R734.2;Q28
[1] LEI L, YANG L Y, XU Y Y, et al. Hepatoid adenocarcinoma of the lung: an analysis of the surveillance, epidemiology, and end results (SEER) database[J]. Open Medicine, 2021, 16(1): 169-174. DOI: 10.1515/med-2021-0215.
[2] HENLEY S J, WARD E M, SCOTT S, et al. Annual report to the nation on the status of cancer, part Ι: National cancer statistics[J]. Cancer, 2020, 126(10):2225-2249. DOI: 10.1002/cncr.32802.
[3] SARAIVA M, O'GARRA A. The regulation of IL-10 production by immune cells[J].Nature Reviews Immunology, 2010, 10(3): 170-181. DOI: 10.1038/nri2711.
[4] FILIPPI C M, VON HERRATH M G. IL-10 and the resolution of infections[J]. Journal of Pathology, 2008, 214(2): 224-230. DOI: 10.1002/path.2272.
[5] RUTZ S, OUYANG W, CRELLIN N K, et al. Regulation and functions of the IL-10 family of cytokines in inflammation and disease[J]. Annual Review of Immunology, 2011, 29(1): 71. DOI: 10.1146/annurev-immunol-031210-101312.
[6] WANG X T, WONG K, OUYANG W J, et al. Targeting IL-10 family cytokines for the treatment of human diseases[J]. Cold Spring Harbor Perspectives in Biology, 2017, 11(2): a028548 DOI: 10.1101/cshperspect.a028548.
[7] 周俊, 陈舒曼, 邢兵, 等. 正常来源CD4+CD25+细胞在小鼠肺癌模型中的抗肿瘤作用[J]. 广西师范大学学报(自然科学版), 2022, 40(2): 191-199. DOI: 10.16088/j.issn.1001-6600.2021022202.
[8] OFT M. IL-10: master switch from tumor-promoting inflammation to antitumor immunity[J]. Cancer Immunology Research, 2014, 2(3): 194-199. DOI: 10.1158/2326-6066.CIR-13-0214.
[9] KHODER A, SARVARIA A, ALSULIMAN A, et al. Regulatory B cells are enriched within the IgM memory and transitional subsets in healthy donors but are deficient in chronic GVHD[J]. Blood, 2014, 124(13): 2034-2045. DOI: 10.1182/blood-2014-04-571125.
[10] WU F Y, WANG L, ZHOU C C. Lung cancer in China: current and prospect[J].Current Opinion in Oncology, 2021, 33(1): 40-46. DOI: 10.1097/CCO.0000000000000703.
[11] NOORELDEEN R, BACH H. Current and future development in lung cancer diagnosis[J]. International Journal of Molecular Sciences, 2021, 22(16):8661. DOI: 10.3390/ijms22168661.
[12] MANNINO M H, ZHU Z W, XIAO H P, et al. The paradoxical role of IL-10 in immunity and cancer[J]. Cancer Letters, 2015, 367(2): 103-107. DOI: 10.1016/j.canlet.2015.07.009.
[13] MIRLEKAR B. Tumor promoting roles of IL-10, TGF-β, IL-4, and IL-35: Its implications in cancer immunotherapy[J]. SAGE Open Medicine, 2022, 10: 20503121211069012. DOI: 10.1177/20503121211069012.
[14] SARAIVA M, VIEIRA P, O'GARRA A. Biology and therapeutic potential of interleukin-10[J].Journal of Experimental Medicine, 2020, 217(1): e20190418. DOI: 10.1084/jem.20190418.
[15] DABITAO D, HEDRICH C M, WANG F Y, et al. Cell-specific requirements for STAT proteins and Type I IFN receptor signaling discretely regulate IL-24 and IL-10 expression in NK cells and macrophages[J]. Journal of Immunology, 2018, 200(6): 2154-2164. DOI: 10.4049/jimmunol.1701340.
[16] WANG X F, LI J, LU C H, et al. IL-10-producing B cells in differentiated thyroid cancer suppress the effector function of T cells but improve their survival upon activation[J]. Experimental Cell Research, 2019, 376(2): 192-197. DOI: 10.1016/j.yexcr.2019.01.021.
[17] HU H T, AI X S, LU M X, et al. Characterization of intratumoral and circulating IL-10-producing B cells in gastric cancer[J]. Experimental Cell Research, 2019, 384(2): 111652. DOI: 10.1016/j.yexcr.2019.111652.
[18] BATCHU R B, GRUZDYN O V, KOLLI B K, et al. IL-10 signaling in the tumor microenvironment of ovarian cancer[J]. Advances in Experimental Medicine and Biology, 2021, 1290: 51-65. DOI: 10.1007/978-3-030-55617-4_3.
[19] POE S L, ARORA M, ORISS T B, et al. STAT1-regulated lung MDSC-like cells produce IL-10 and efferocytose apoptotic neutrophils with relevance in resolution of bacterial pneumonia[J]. Mucosal Immunology, 2013, 6(1): 189-199. DOI: 10.1038/mi.2012.62.
[20] DIEFENHARDT P, NOSKO A, KLUGER M A, et al. IL-10 receptor signaling empowers regulatory T cells to control Th17 responses and protect from GN[J]. Journal of the American Society of Nephrology, 2018, 29(7):1825-1837. DOI: 10.1681/ASN.2017091044.
[21] LI F Z, DHILLON A S, ANDERSON R L, et al. Phenotype switching in melanoma: implications for progression and therapy[J]. Frontiers in Oncology, 2015, 5:31. DOI: 10.3389/fonc.2015.00031.
[22] PEREIRA A P L, TRUGILO K P, OKUYAMA N C M, et al. IL-10 c.-592C>A (rs1800872) polymorphism is associated with cervical cancer[J]. Journal of Cancer Research and Clinical Oncology, 2020, 146(8): 1971-1978. DOI: 10.1007/s00432-020-03256-0.
[23] MOGHIMI M, AHRAR H, KARIMI-ZARCHI M, et al. Association of IL-10 rs1800871 and rs1800872 polymorphisms with breast cancer risk: a systematic review and meta-analysis[J]. Asian Pacific Journal of Cancer Prevention, 2018, 19(12): 3353-3359. DOI: 10.31557/apjcp.2018.19.12.3353.
[24] NAING A, INFANTE J R, PAPADOPOULOS K P, et al. PEGylated IL-10 (Pegilodecakin)induces systemic immune activation, CD8+ T cell invigoration and polyclonal T cell expansion in cancer patients[J]. Cancer Cell, 2018, 34(5): 775-791. DOI: 10.1016/j.ccell.2018.10.007.
[25] NAING A, PAPADOPOULOS K P, AUTIO K A, et al. Safety, antitumor activity, and immune activation of pegylated recombinant human interleukin-10 (AM0010) in patients with advanced solid tumors[J]. Journal of Clinical Oncology, 2016, 34(29): 3562-3569. DOI: 10.1200/JCO.2016.68.1106.
[26] LU Z W, HU J Q, LIU W L, et al. IL-10 restores MHC class I expression and interferes with immunity in papillary thyroid cancer with hashimoto thyroiditis[J]. Endocrinology, 2020, 161(10): bqaa062. DOI: 10.1210/endocr/bqaa062.
[27] OUYANG W J, O'GARRA A. IL-10 family cytokines IL-10 and IL-22: from basic science to clinical translation[J]. Immunity, 2019, 50(4): 871-891. DOI: 10.1016/j.immuni.2019.03.020.
[28] CHANG C M, LAM H Y P, HSU H J, et al. Interleukin-10: A double-edged sword in breast cancer[J].Tzu Chi Medical Journal, 2021, 33(3): 203-211. DOI: 10.4103/tcmj.tcmj_162_20.
[1] WANG Qintian, SHEN Yanjun. Multi-stage Coyote Optimization Algorithm [J]. Journal of Guangxi Normal University(Natural Science Edition), 2023, 41(3): 105-117.
[2] ZHAO Tingting, YANG Fenglian. B-Spline Method for the Cauchy Problem of the Laplace Equation [J]. Journal of Guangxi Normal University(Natural Science Edition), 2023, 41(3): 118-129.
[3] HE Fangyuang, SU Quan, CHEN Kunquan, CHEN Shandong, JIANG Yong, LUO Ming, LIANG Shichu. Exploring Community Assembly of Guilin Karst Hills Based on Functional Traits and Phylogeny [J]. Journal of Guangxi Normal University(Natural Science Edition), 2023, 41(3): 171-181.
[4] SONG Bing, ZHANG Yuru, SANG Yuan, ZHANG Long. Stability of an HIV Immune Model with Saturation Incidence and Distributed Delays [J]. Journal of Guangxi Normal University(Natural Science Edition), 2023, 41(2): 106-117.
[5] WEI Mingjun, ZHOU Taiyu, JI Zhanlin, ZHANG Xinnan. Detection Method of Mask Wearing in Public Places Based on YOLOv3 [J]. Journal of Guangxi Normal University(Natural Science Edition), 2023, 41(1): 76-86.
[6] DU Jierui, CUI Xia, LI Yuan. Estimating Interaction Effects Between a Treatment and Covariates Using the Rubin Causal Model [J]. Journal of Guangxi Normal University(Natural Science Edition), 2023, 41(1): 122-130.
[7] ZHANG Limeng, LI Runting, NIE Xiaoning, LI Yuhua, LI Lin, LI Yameng, CHEN Longxin, WANG Linqing. Physicochemical Properties and Bioinformatics Analysis of Somatostatin Receptor 2 (SSTR2) [J]. Journal of Guangxi Normal University(Natural Science Edition), 2023, 41(1): 164-173.
[8] ZHANG Chunmei, YAN Fang, SONG Hai, ZHANG Xifeng , CHEN Ye. Sequencing and Bioinformatic Analysis for Transcriptome of Shandan Sphallerocarpus racills Leaf [J]. Journal of Guangxi Normal University(Natural Science Edition), 2022, 40(6): 247-256.
[9] LÜ Jiahua, ZHU Chan, TANG Zongxiang. Formation Mechanism and Biological Significance of Bitterness in Traditional Chinese Medicine [J]. Journal of Guangxi Normal University(Natural Science Edition), 2022, 40(5): 324-331.
[10] CHEN Ying, ZHOU Zuping, XING Bing, PU Shiming. Construction of the Slfn2 Knockout Cell Lines in Lewis Lung Carcinoma Model Based on CRISPR/Cas9 System [J]. Journal of Guangxi Normal University(Natural Science Edition), 2022, 40(4): 173-179.
[11] ZHAO Junyu, SHI Yuanyuan, QIN Zuoyu, PAN Bo, HUANG Xiaorui, TANG Jian. Analysis and Evaluation of Soil Fertility Obstacle Factors in Eucalyptus Plantation in South Subtropical Region [J]. Journal of Guangxi Normal University(Natural Science Edition), 2022, 40(4): 205-214.
[12] BAI Shangwang, MA Xiaoqian, GAO Gaimei, LIU Chunxia, DANG Weichao. Byzantine Fault Tolerant Consensus Algorithm Based on Verifiable Random Function and BLS Signature [J]. Journal of Guangxi Normal University(Natural Science Edition), 2022, 40(3): 194-201.
[13] ZHOU Jun, CHEN Shuman, XING Bing, CHEN Yajing, LI Yinling, HE Liu, ZHOU Zuping, PU Shiming. Antitumor Effect of Normal Mice Derived CD4+CD25+ Cells in Mice Lung Cancer Model [J]. Journal of Guangxi Normal University(Natural Science Edition), 2022, 40(2): 191-199.
[14] FENG Yueting, WEI Zhouquan, HUANG Zhonghao, LI Youbang. Comparative Study on Allgrooming Behavior of White-headed Langur (Trachypithecus leucocephalus) and François' langur (Trachypithecus francoisi) Living in Guangxi, China [J]. Journal of Guangxi Normal University(Natural Science Edition), 2022, 40(2): 208-217.
[15] BAI Defa, XU Xin, WANG Guochang. Review of Generalized Linear Models and Classification for Functional Data [J]. Journal of Guangxi Normal University(Natural Science Edition), 2022, 40(1): 15-29.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
[1] XU Qin, MA Chaomei, RAO Weiwen, DENG Lidong. Quantification of Twelve Constituents in the Extracts of Folium ficim icrocarpaeby Ultra-performence Liquid Chromatography-Quadropole Mass Spectrometry[J]. Journal of Guangxi Normal University(Natural Science Edition), 2017, 35(2): 80 -86 .
[2] ZHOU Wei, SUN Chao, ZHOU Haitao. Nomenclatural Status Textual Criticism about Two Species of Garrafrom Lancangjiang(the Upper Mekong), China[J]. Journal of Guangxi Normal University(Natural Science Edition), 2017, 35(2): 117 -125 .
[3] LI Jianhong, MENG Xinyuan, ZHAI Luxin, WANG Yue. Analysis of the Trend of Extreme Continuous Precipitation underClimate Change Condition in Guangxi,China, from 1951 to 2006[J]. Journal of Guangxi Normal University(Natural Science Edition), 2016, 34(1): 187 -196 .
[4] LUO Raoshan, SHEN Yanling, SUN Liyuan. Protective Effect of Magnesium-L-Threonateon Dopamine Neurons and Its Mechanism[J]. Journal of Guangxi Normal University(Natural Science Edition), 2018, 36(4): 124 -130 .
[5] CHEN Mei-hong, YANG Cui-hong, LI Chuan-qi. Influence of Geosynchronous Satellites on Earth Rotation Angular Velocity and Coriolis Force[J]. Journal of Guangxi Normal University(Natural Science Edition), 2011, 29(2): 6 -9 .
[6] LIANG Bixia, HUANG Jinlong, HAN Lixia,WU Zhengjun. Winter Fertility of Pomacea canaliculata in Guilin,China[J]. Journal of Guangxi Normal University(Natural Science Edition), 2019, 37(3): 166 -173 .
[7] LIU Jing, BIAN Xun. Characteristics of the Orthoptera Mitogenome and Its Application[J]. Journal of Guangxi Normal University(Natural Science Edition), 2021, 39(1): 17 -28 .
[8] CHENG Rui, HE Mingxian, ZHONG Chunying, LUO Shuyi, WU Zhengjun. Comparison of Swimming Ability between Wild and Captive Breeding Shinisaurus crocodilurus[J]. Journal of Guangxi Normal University(Natural Science Edition), 2021, 39(1): 79 -86 .
[9] PENG Tao, TANG Jing, HE Kai, HU Xinrong, LIU Junping, HE Ruhan. Emotion Recognition Based on Multi-gait Feature Fusion[J]. Journal of Guangxi Normal University(Natural Science Edition), 2022, 40(3): 104 -111 .
[10] CHEN Gaojian, WANG Jing, LI Qianwen, YUAN Yunjing, CAO Jiachen. Data-driven Method for Automatic Machine Learning Pipeline Generation[J]. Journal of Guangxi Normal University(Natural Science Edition), 2022, 40(3): 185 -193 .
Copyright © Journal of Guangxi Normal University(Natural Science Edition), All Rights Reserved.
Tel: 0773-5857325　E-mail: gxsdzkb@mailbox.gxnu.edu.cn
Powered by Beijing Magtech Co. Ltd